Drugs that contain Desvenlafaxine Succinate

1. Drug name - PRISTIQ

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US6673838 PF PRISM CV Succinate salt of O-desmethyl-venlafaxine
Mar, 2022

(6 months ago)

US8269040 PF PRISM CV Derivatives of venlafaxine and methods of preparing and using the same
Jul, 2027

(4 years from now)

CN100567253C PF PRISM CV O-Desmethyl-Venlafaxine Succinate
Feb, 2022

(7 months ago)

CN1501909A PF PRISM CV A New O-Demethyl-Venlafaxine Succinate
Feb, 2022

(7 months ago)

IN201649B PF PRISM CV Novel Succinate Salt Of O-Desmethyl- Venlafaxine
Feb, 2022

(7 months ago)

IN200301015P2 PF PRISM CV Novel Succinate Salt Of O-Desmethyl-Venlafaxine
Feb, 2022

(7 months ago)

EP1466889B1 PF PRISM CV O-Desmethylvenlafaxine Succinate
Mar, 2020

(2 years ago)

EP1466889A1 PF PRISM CV O-Desmethylvenlafaxine Succinate
Mar, 2020

(2 years ago)

EP1360169B2 PF PRISM CV Succinate Salt Of O-Desmethyl-Venlafaxine
Feb, 2022

(7 months ago)

EP1360169A2 PF PRISM CV Succinate Salt Of O-Desmethyl-Venlafaxine
Feb, 2022

(7 months ago)

EP1360169B1 PF PRISM CV Succinate Salt Of O-Desmethyl-Venlafaxine
Feb, 2022

(7 months ago)

Treatment: NA

Dosage: TABLET, EXTENDED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
EQ 25MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription
EQ 50MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription
EQ 100MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.